BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38314727)

  • 1. S100b treatment overcomes RAGE signaling deficits in myoblasts on advanced glycation end-product cross-linked collagen and promotes myogenic differentiation.
    Olson LC; Nguyen T; Sabalewski EL; Puetzer JL; Schwartz Z; McClure MJ
    Am J Physiol Cell Physiol; 2024 Apr; 326(4):C1080-C1093. PubMed ID: 38314727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. S100B engages RAGE or bFGF/FGFR1 in myoblasts depending on its own concentration and myoblast density. Implications for muscle regeneration.
    Riuzzi F; Sorci G; Beccafico S; Donato R
    PLoS One; 2012; 7(1):e28700. PubMed ID: 22276098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced glycation end products inhibit proliferation and primary cilia formation of myoblasts through receptor for advanced glycation end products pathway.
    Suzuki S; Hayashi T; Egawa T
    Biochem Biophys Res Commun; 2023 Dec; 684():149141. PubMed ID: 37897908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The amphoterin (HMGB1)/receptor for advanced glycation end products (RAGE) pair modulates myoblast proliferation, apoptosis, adhesiveness, migration, and invasiveness. Functional inactivation of RAGE in L6 myoblasts results in tumor formation in vivo.
    Riuzzi F; Sorci G; Donato R
    J Biol Chem; 2006 Mar; 281(12):8242-53. PubMed ID: 16407300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amphoterin stimulates myogenesis and counteracts the antimyogenic factors basic fibroblast growth factor and S100B via RAGE binding.
    Sorci G; Riuzzi F; Arcuri C; Giambanco I; Donato R
    Mol Cell Biol; 2004 Jun; 24(11):4880-94. PubMed ID: 15143181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. S100B causes apoptosis in a myoblast cell line in a RAGE-independent manner.
    Sorci G; Riuzzi F; Agneletti AL; Marchetti C; Donato R
    J Cell Physiol; 2004 May; 199(2):274-83. PubMed ID: 15040010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100B protein regulates myoblast proliferation and differentiation by activating FGFR1 in a bFGF-dependent manner.
    Riuzzi F; Sorci G; Donato R
    J Cell Sci; 2011 Jul; 124(Pt 14):2389-400. PubMed ID: 21693575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100B inhibits myogenic differentiation and myotube formation in a RAGE-independent manner.
    Sorci G; Riuzzi F; Agneletti AL; Marchetti C; Donato R
    Mol Cell Biol; 2003 Jul; 23(14):4870-81. PubMed ID: 12832473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced glycation end-products induce skeletal muscle atrophy and dysfunction in diabetic mice via a RAGE-mediated, AMPK-down-regulated, Akt pathway.
    Chiu CY; Yang RS; Sheu ML; Chan DC; Yang TH; Tsai KS; Chiang CK; Liu SH
    J Pathol; 2016 Feb; 238(3):470-82. PubMed ID: 26586640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of pyridinoline, a collagen crosslink, as a novel intrinsic ligand for the receptor for advanced glycation end-products (RAGE).
    Murakami Y; Fujino T; Kurachi R; Hasegawa T; Usui T; Hayase F; Watanabe H
    Biosci Biotechnol Biochem; 2018 Sep; 82(9):1508-1514. PubMed ID: 29804507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylglyoxal - an advanced glycation end products (AGEs) precursor - Inhibits differentiation of human MSC-derived osteoblasts in vitro independently of receptor for AGEs (RAGE).
    Waqas K; Muller M; Koedam M; El Kadi Y; Zillikens MC; van der Eerden BCJ
    Bone; 2022 Nov; 164():116526. PubMed ID: 35995334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia.
    Chiappalupi S; Sorci G; Vukasinovic A; Salvadori L; Sagheddu R; Coletti D; Renga G; Romani L; Donato R; Riuzzi F
    J Cachexia Sarcopenia Muscle; 2020 Aug; 11(4):929-946. PubMed ID: 32159297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advanced glycation end products decrease collagen I levels in fibroblasts from the vaginal wall of patients with POP via the RAGE, MAPK and NF-κB pathways.
    Chen YS; Wang XJ; Feng W; Hua KQ
    Int J Mol Med; 2017 Oct; 40(4):987-998. PubMed ID: 28849117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle progenitors are sensitive to collagen architectural features of fibril size and cross linking.
    Hu LY; Mileti CJ; Loomis T; Brashear SE; Ahmad S; Chellakudam RR; Wohlgemuth RP; Gionet-Gonzales MA; Leach JK; Smith LR
    Am J Physiol Cell Physiol; 2021 Aug; 321(2):C330-C342. PubMed ID: 34191625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired oligodendrogenesis and myelination by elevated S100B levels during neurodevelopment.
    Santos G; Barateiro A; Gomes CM; Brites D; Fernandes A
    Neuropharmacology; 2018 Feb; 129():69-83. PubMed ID: 29126910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE expression in rhabdomyosarcoma cells results in myogenic differentiation and reduced proliferation, migration, invasiveness, and tumor growth.
    Riuzzi F; Sorci G; Donato R
    Am J Pathol; 2007 Sep; 171(3):947-61. PubMed ID: 17640970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term pharmacologic RAGE inhibition differentially affects bone and skeletal muscle in middle-aged mice.
    Davis HM; Essex AL; Valdez S; Deosthale PJ; Aref MW; Allen MR; Bonetto A; Plotkin LI
    Bone; 2019 Jul; 124():89-102. PubMed ID: 31028960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cyclooxygenase-2 expression in monocytes by ligation of the receptor for advanced glycation end products.
    Shanmugam N; Kim YS; Lanting L; Natarajan R
    J Biol Chem; 2003 Sep; 278(37):34834-44. PubMed ID: 12837757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human muscle satellite cells show age-related differential expression of S100B protein and RAGE.
    Beccafico S; Riuzzi F; Puglielli C; Mancinelli R; Fulle S; Sorci G; Donato R
    Age (Dordr); 2011 Dec; 33(4):523-41. PubMed ID: 21140295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylglyoxal and Advanced Glycation End products: Insight of the regulatory machinery affecting the myogenic program and of its modulation by natural compounds.
    Baig MH; Jan AT; Rabbani G; Ahmad K; Ashraf JM; Kim T; Min HS; Lee YH; Cho WK; Ma JY; Lee EJ; Choi I
    Sci Rep; 2017 Jul; 7(1):5916. PubMed ID: 28725008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.